Synthesized peptide of the L-amino acids with the sequence H-Lys-Glu-Phe-Leu-His-Pro-Ser-Lys-Val-Asp-Leu-Pro-Arg-OH

	Synthesized peptide of the L-amino acids with the sequence H-Lys-Glu-Phe-Leu-His-Pro-Ser-Lys-Val-Asp-Leu-Pro-Arg-OH
Trade Name
Orphan Indication	Ovarian cancer
USA Market Approval	USA
USA Designation Date	2016-02-04 00:00:00
Sponsor	Soricimed Biopharma Inc.;18 Botsford Street, Suite 201;Moncton, New Brunswick

Related Access Program

AstraZeneca – PSR Ovarian Cancer With a BRCA Mutation Tesaro, Inc. – Recurrent Ovarian Cancer AstraZeneca – Ovarian Cancer